1. Home
  2. TCBP vs LIFW Comparison

TCBP vs LIFW Comparison

Compare TCBP & LIFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBP
  • LIFW
  • Stock Information
  • Founded
  • TCBP 2013
  • LIFW 2014
  • Country
  • TCBP United Kingdom
  • LIFW United States
  • Employees
  • TCBP N/A
  • LIFW N/A
  • Industry
  • TCBP Biotechnology: Biological Products (No Diagnostic Substances)
  • LIFW Computer Software: Prepackaged Software
  • Sector
  • TCBP Health Care
  • LIFW Technology
  • Exchange
  • TCBP Nasdaq
  • LIFW Nasdaq
  • Market Cap
  • TCBP 3.0M
  • LIFW 2.8M
  • IPO Year
  • TCBP 2022
  • LIFW N/A
  • Fundamental
  • Price
  • TCBP $0.68
  • LIFW $0.07
  • Analyst Decision
  • TCBP
  • LIFW
  • Analyst Count
  • TCBP 0
  • LIFW 0
  • Target Price
  • TCBP N/A
  • LIFW N/A
  • AVG Volume (30 Days)
  • TCBP 3.0M
  • LIFW 16.3M
  • Earning Date
  • TCBP 11-29-2024
  • LIFW 11-14-2024
  • Dividend Yield
  • TCBP N/A
  • LIFW N/A
  • EPS Growth
  • TCBP N/A
  • LIFW N/A
  • EPS
  • TCBP N/A
  • LIFW N/A
  • Revenue
  • TCBP N/A
  • LIFW $10,734,000.00
  • Revenue This Year
  • TCBP N/A
  • LIFW $293,208.70
  • Revenue Next Year
  • TCBP N/A
  • LIFW N/A
  • P/E Ratio
  • TCBP N/A
  • LIFW N/A
  • Revenue Growth
  • TCBP N/A
  • LIFW 217.86
  • 52 Week Low
  • TCBP $0.56
  • LIFW $0.06
  • 52 Week High
  • TCBP $138.00
  • LIFW $7.10
  • Technical
  • Relative Strength Index (RSI)
  • TCBP 23.01
  • LIFW 27.68
  • Support Level
  • TCBP $1.05
  • LIFW $0.08
  • Resistance Level
  • TCBP $1.25
  • LIFW $0.20
  • Average True Range (ATR)
  • TCBP 0.22
  • LIFW 0.03
  • MACD
  • TCBP 0.06
  • LIFW -0.00
  • Stochastic Oscillator
  • TCBP 10.36
  • LIFW 8.49

About TCBP TC BioPharm (Holdings) plc

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

About LIFW MSP Recovery Inc.

MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.

Share on Social Networks: